Rifaximin is used for: Traveler's diarrhea; irritable bowel syndrome.
Recorded in the NepalDoc medicine catalog for Rifaximin.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN when used to treat infection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy.
From the U.S. FDA-approved label for Rifaximin. Full label: DailyMed.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN when used to treat infection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. XIFAXAN is a rifamycin antibacterial indicated for: Treatment of travelers’ diarrhea (TD) caused by noninvasive strains of Escherichia coli in adult and pediatric patients 12 years of age and older., Reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults., Treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.
From the U.S. FDA-approved label for Rifaximin. Full label: DailyMed.
Condition Recommended Oral Dosage TD 200 mg 3 times a day for 3 days HE 550 mg 2 times a day IBS-D 550 mg 3 times a day for 14 days. Patients who experience recurrence can be retreated up to 2 times with the same regimen. XIFAXAN can be taken with or without food.
Directions from the U.S. FDA-approved label for Rifaximin — your doctor or pharmacist may advise differently.
XIFAXAN is contraindicated in patients with a hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in XIFAXAN. Hypersensitivity reactions have included exfoliative dermatitis, angioneurotic edema, and anaphylaxis. History of hypersensitivity to rifaximin, rifamycin antimicrobial agents, or any of the components of XIFAXAN.
Excerpt from the U.S. FDA-approved label for Rifaximin. Talk to a pharmacist or doctor before use.
Travelers’ Diarrhea Not Caused by E. coli: XIFAXAN was not effective in diarrhea complicated by fever and/or blood in the stool or diarrhea due to pathogens other than E.
Warnings and precautions excerpt from the U.S. FDA-approved label for Rifaximin — not a complete list. Talk to a pharmacist or doctor before use.
The following clinically significant adverse reactions are described elsewhere in labeling: Clostridium difficile -associated diarrhea Most common adverse reactions: TD (≥2%): Headache, HE (≥10%): Peripheral edema, nausea, constipation, dizziness, fatigue, urinary tract infection, insomnia, anemia, pruritus, and ascites, IBS-D (≥2%): ALT increased, nausea To report SUSPECTED ADVERSE REACTIONS, contact Salix Pharmaceuticals at…
Excerpt from the U.S. FDA-approved label for Rifaximin — not a complete list. Talk to a pharmacist or doctor about side effects.
6 brands · 4 makers in the NepalDoc catalog — see the full Rifaximin guide →
Storage Store XIFAXAN Tablets at 20° to 25°C (68° to 77°F);
Storage information from the U.S. FDA-approved label for Rifaximin.
What is Rifazex?
Rifazex 550 mg Tablet is a Rifaximin medicine made by QbD Pharmaceuticals. It comes as 550 mg Tablet.
What is Rifazex used for?
Rifaximin is used for Traveler's diarrhea, irritable bowel syndrome.
What is the generic name of Rifazex?
The generic name of Rifazex is Rifaximin.
Which brands of Rifaximin are available in Nepal?
6 brands of Rifaximin are listed in the NepalDoc catalog, from 4 makers — including Dufaximin 400mg Tablet, Dufaximin 550mg Tablet, Rifabac 200mg Tablet, Rifabac 550mg Tablet, Rifaxim 550mg Tablet.
What are the side effects of Rifaximin?
The following clinically significant adverse reactions are described elsewhere in labeling: Clostridium difficile -associated diarrhea Most common adverse reactions: TD (≥2%): Headache, HE (≥10%): Peripheral edema, nausea, constipation, dizziness, fatigue, urinary tract infection, insomnia, anemia, pruritus, and ascites, IBS-D (≥2%): ALT increased, nausea To report SUSPECTED ADVERSE REACTIONS, contact Salix Pharmaceuticals at…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
